Dalton, James T.,Wu, Zhongzhi,Miller, Duane D.,Mohler, Michael L.,Hong, Seoung-Soo,Srivastava, Devesh
申请号：
AU2008209581
公开号：
AU2008209581B2
申请日:
2008.01.22
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
The present invention relates to a novel class of nuclear receptor binding agents(NRBAs). The NRBAs are applicable for use in the prevention and/or treatmentof a variety of diseases and conditions including prevention and treatment ofcancers such as prostate and breast cancer, osteoporosis, hormone-relateddiseases, inflammatory diseases, oxidative stress related disorders suchas Parkinson's and stroke, neurological disorders, ophthalamic disorders,cardiovascular disease, and obesity.
